AAPL 258.8189 0.2397% MSFT 439.14 -0.0432% NVDA 140.185 -0.025% GOOGL 196.0128 -0.0496% GOOG 197.54 -0.0152% AMZN 227.87 -0.5152% META 603.74 -0.6598% AVGO 245.6915 2.5081% TSLA 452.9125 -2.0264% TSM 204.19 -1.0372% LLY 797.2122 0.1938% V 320.96 0.0967% JPM 242.37 0.0248% UNH 509.62 0.6955% NVO 87.85 0.5494% WMT 92.38 -0.3237% LVMUY 132.91 0.4459% XOM 106.31 -0.0846% LVMHF 664.0 0.9119% MA 536.2159 0.0944%

MultiPlan Corporation

Healthcare US MPLN

12.53USD
0.29(2.37%)

Last update at 2024-12-26T18:51:00Z

Day Range

10.4313.29
LowHigh

52 Week Range

0.612.29
LowHigh

Fundamentals

  • Previous Close 12.24
  • Market Cap1104.13M
  • Volume523258
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA631.56M
  • Revenue TTM958.48M
  • Revenue Per Share TTM1.49
  • Gross Profit TTM 875.62M
  • Diluted EPS TTM-1.11

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -560.74300M 135.45M -555.96900M 10.51M 44.33M
Minority interest - - - - -
Net income -572.91200M 102.08M -529.62600M 9.71M 36.22M
Selling general administrative 166.84M 151.09M 355.63M 75.22M 77.56M
Selling and marketing expenses - - - - -
Gross profit 875.62M 942.31M 619.09M 833.29M 891.42M
Reconciled depreciation 415.66M 412.06M 403.68M 399.45M 386.32M
Ebit 302.99M 386.12M -105.17300M 368.21M 427.59M
Ebitda 718.65M 798.21M 298.51M 758.26M 813.91M
Depreciation and amortization 415.66M 412.09M 403.68M 390.06M 386.32M
Non operating income net other 38.34M -15.78800M -114.87000M - -
Operating income 302.99M 386.12M -105.17300M 368.21M 427.54M
Other operating expenses 780.23M 731.48M 1069.58M 614.69M 613.34M
Interest expense 303.40M 267.48M 335.64M 376.35M 383.26M
Tax provision 12.17M 33.37M -26.34300M 0.80M 8.11M
Interest income 3.50M 0.03M 0.29M 0.20M 0.05M
Net interest income -299.90100M -267.44500M -335.35000M -376.15000M -383.21000M
Extraordinary items - - - - -
Non recurring 662.22M - - - -
Other items - - - - -
Income tax expense 12.17M 33.37M -26.34300M 0.80M 8.11M
Total revenue 1079.72M 1117.60M 937.76M 982.90M 1040.88M
Total operating expenses 576.13M 556.19M 750.91M 465.08M 463.88M
Cost of revenue 204.10M 175.29M 318.68M 149.61M 149.46M
Total other income expense net -863.73200M -250.66700M -450.79600M -357.70000M -383.21000M
Discontinued operations - - - - -
Net income from continuing ops -572.91200M 102.08M -529.62600M 9.71M 36.22M
Net income applicable to common shares -572.91200M 102.08M -520.56400M 9.71M 36.22M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 7371.10M 8220.41M 8283.58M 8360.41M -
Intangible assets 2940.20M 3285.04M 3584.19M 3886.64M -
Earning assets - - - - -
Other current assets 3.68M 1.00M 1.19M 0.20M -
Total liab 5580.56M 5875.74M 5689.66M 6375.19M -
Total stockholder equity 1790.54M 2344.67M 2593.92M 1985.22M -
Deferred long term liab 639.50M 753.83M 900.63M - -
Other current liab -496.56200M 108.77M 90.80M 66.70M -
Common stock 0.07M 0.07M 0.07M 0.04M -
Capital stock 0.07M 0.07M 0.07M 0.04M -
Retained earnings -347.80000M 225.11M 107.94M 637.56M 627.85M
Other liab 641.97M 827.96M 1007.23M 869.20M 984.01M
Good will 3705.20M 4363.07M 4257.34M 4142.01M -
Other assets 21.89M 9.70M 14.23M 8.15M 6.10M
Cash 334.05M 185.33M 126.75M 21.82M -
Cash and equivalents - - - - -
Total current liabilities 175.84M 141.91M 112.50M 85.79M 65.16M
Current deferred revenue 639.50M - - - -
Net debt 4448.32M 4740.67M 4485.67M 5407.90M -
Short term debt 19.61M 20.13M 6.44M 9.52M -
Short long term debt 13.25M 13.25M - - -
Short long term debt total 4782.36M 4926.00M 4612.43M 5429.73M -
Other stockholder equity 2138.28M 2119.49M 2485.91M 1347.66M -
Property plant equipment 51.49M 243.34M 51.07M 47.69M 20.11M
Total current assets 446.74M 319.26M 208.85M 115.61M 105.68M
Long term investments - - - - -
Net tangible assets -4854.85800M -5303.43700M -5451.55400M -6203.73800M -6520.69200M
Short term investments - - - - -
Net receivables 78.91M 99.91M 63.20M 77.07M 82.35M
Long term debt 4741.86M 4879.14M 4578.49M 5397.02M -
Inventory 30.11M 33.02M 17.71M 2.13M -
Accounts payable 13.29M 13.01M 15.26M 9.56M 10.85M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -243.28300M -184.35100M -
Additional paid in capital - - - - -
Common stock total equity 0.07M 0.07M 0.07M 0.04M -
Preferred stock total equity - - - - -
Retained earnings total equity -347.80000M 225.11M 117.00M - -
Treasury stock -192.16900M -192.16900M -89.61000M - -
Accumulated amortization - - - - -
Non currrent assets other -617.60300M 9.70M 14.23M 8.15M -
Deferred long term asset charges - - - - -
Non current assets total 6924.37M 7901.15M 8074.72M 8244.80M -
Capital lease obligations 27.26M 33.61M 33.94M 32.71M -
Long term debt total 4741.86M 4879.14M 4578.49M - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -104.44600M 5.64M -210.84500M -66.41400M -63.55600M
Change to liabilities 34.35M 7.71M 29.07M 20.78M -40.35000M
Total cashflows from investing activities -104.44600M -228.37900M -210.84500M -66.41400M -63.55600M
Net borrowings -113.24900M -10.89500M -619.39500M -201.08800M -245.15000M
Total cash from financing activities -115.73800M -114.68400M -61.59900M -201.08800M -245.15000M
Change to operating activities -3.72500M -12.85200M -15.94100M -18.28400M -4.68100M
Net income -572.91200M 102.08M -529.62600M 9.71M 36.22M
Change in cash 152.18M 61.62M 104.93M 16.81M -16.40300M
Begin period cash flow 188.38M 126.75M 21.82M 5.01M 21.42M
End period cash flow 340.56M 188.38M 126.75M 21.82M 5.01M
Total cash from operating activities 372.36M 404.69M 377.37M 284.31M 292.30M
Issuance of capital stock - - - - -
Depreciation 415.66M 412.06M 403.68M 389.86M 386.32M
Other cashflows from investing activities - -149.43000M -140.03200M - -
Dividends paid - - - 0.00000M -
Change to inventory - - - - 40.35M
Change to account receivables 21.00M -33.82600M 14.76M 5.28M 3.02M
Sale purchase of stock 0.00000M -100.00000M -101.12300M 0.00000M 0.00000M
Other cashflows from financing activities -2.48900M 2329.66M 3324.42M -66.41400M 5.00M
Change to netincome 541.62M -65.42200M 464.25M -131.20300M -92.63100M
Capital expenditures 89.73M 84.59M 70.81M 66.41M 63.56M
Change receivables 21.00M -33.82600M 14.76M - -
Cash flows other operating -60.98400M -43.54900M -5.40600M - -
Exchange rate changes - - - - -
Cash and cash equivalents changes 152.18M 61.62M 104.93M - -
Change in working capital 55.34M -44.02900M 30.01M 15.95M -37.61000M
Stock based compensation 16.74M 18.01M 406.05M -14.88000M 4.72M
Other non cash items 571.92M -1.50300M 112.30M -4.91900M 15.13M
Free cash flow 282.63M 320.10M 306.56M 217.90M 228.75M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MPLN
MultiPlan Corporation
0.29 2.37% 12.53 - - 1.13 0.60 5.78 179.12
GEHC
GE HealthCare Technologies Inc.
0.63 0.79% 79.99 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A
-4.88 2.24% 212.55 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc
- -% 9.73 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc
-0.04 0.92% 4.29 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

Profile

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It also provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. The company serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

MultiPlan Corporation

115 Fifth Avenue, New York, NY, United States, 10003

Key Executives

Name Title Year Born
Mr. Dale A. White Pres, CEO & Director 1956
Mr. James M. Head CFO & Exec. VP 1966
Mr. Michael C. Kim Sr. VP & Chief Information Officer 1967
Mr. Jeffrey A. Doctoroff Sr. VP, Gen. Counsel & Sec. 1969
Mr. Gerald J. Kozel Sr. VP & Chief Accounting Officer 1972
Mr. Lucas Gabriel Montgomery C.F.A. Sr. VP of Fin. & Investor Relations NA
Pamela Walker Sr. Director of Marketing & Communications NA
Ms. Susan Mohler Sr. VP of Marketing & Product Management NA
Mr. Alwyn van Heerden VP of Strategy & Corp. Devel. NA
Mr. Derek Reis-Larson Sr. VP of Claims Pricing Services NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.